ArticleJournal of the advanced practitioner in oncology2026
Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program.
Article in Journal of the advanced practitioner in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immune thrombocytopenia (ITP) is a rare autoimmune disorder resulting in reduced platelet count. The annual incidence is 3.3 per 100,000 adults and 8.8 per 100,000 person-years in children. Immune thrombocytopenia impacts the quality of life, productivity, and psychosocial well-being of patients and caregivers. This quality improvement study aims to characterize needs of patients, caregivers, and health-care providers (HCPs) managing chronic ITP to improve management in the future. Methods: We conducted a two-session Learning Exchange program: one with HCPs and adult patients, and one with HCPs and caregivers of pediatric patients. Discussions encompassed clinical and personal experiences with chronic ITP, the health-care system, and support resources. Session transcripts identified key themes, which participants subsequently prioritized in a post-meeting survey. Results: A total of 7 patients, 6 caregivers, and 14 HCPs participated in the Learning Exchange sessions, discussing challenges in chronic ITP management and areas for improvement. Post-meeting surveys identified shared priorities, ranked as follows: (1) empowering patients to self-advocate; (2) strengthening shared decision-making; (3) improving resources and support; (4) following the evolving treatment landscape; and (5) mental health support. Conclusions: The sessions identified key needs involving improved education for patients, caregivers, and HCPs; improved communication between patients, caregivers, and HCPs; the greater need for self-advocacy and shared decision-making; and the desire for better support resources and networks. This knowledge will enable the development of improved educational resources, support programs, and future research to benefit the chronic ITP community and improve the quality of management of chronic ITP for patients, caregivers, and HCPs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.